Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Editas Medicine, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 47,755 shares of EDIT stock, worth $115,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,755

Previous 52,254 8.61%

Holding current value

$115,089

Previous $244,000 33.61%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.39 - $5.96 $15,251 - $26,814	-4,499 Reduced 8.61%	47,755 $162,000
Q2 2024 Aug 12, 2024	BUY	$4.67 - $7.28 $142,785 - $222,586	30,575 Added 141.04%	52,254 $244,000
Q1 2024 May 09, 2024	SELL	$7.03 - $11.07 $6,980 - $10,992	-993 Reduced 4.38%	21,679 $160,000
Q4 2023 Feb 08, 2024	SELL	$6.25 - $11.11 $41,968 - $74,603	-6,715 Reduced 22.85%	22,672 $229,000
Q2 2023 Aug 09, 2023	BUY	$6.36 - $11.47 $29,752 - $53,656	4,678 Added 18.93%	29,387 $241,000
Q1 2023 May 08, 2023	BUY	$7.03 - $11.53 $12,344 - $20,246	1,756 Added 7.65%	24,709 $179,000
Q4 2022 Feb 07, 2023	SELL	$8.32 - $13.21 $615 - $977	-74 Reduced 0.32%	22,953 $203,000
Q3 2022 Nov 01, 2022	BUY	$12.16 - $19.42 $4,462 - $7,127	367 Added 1.62%	23,027 $282,000
Q2 2022 Aug 04, 2022	BUY	$9.99 - $21.35 $137,072 - $292,943	13,721 Added 153.5%	22,660 $268,000
Q1 2022 May 09, 2022	BUY	$14.08 - $27.63 $14,206 - $27,878	1,009 Added 12.72%	8,939 $170,000
Q4 2021 Feb 07, 2022	SELL	$26.55 - $40.57 $34,382 - $52,538	-1,295 Reduced 14.04%	7,930 $219,000
Q3 2021 Nov 04, 2021	BUY	$39.27 - $72.94 $8,639 - $16,046	220 Added 2.44%	9,225 $379,000
Q2 2021 Aug 06, 2021	SELL	$31.29 - $56.64 $121,373 - $219,706	-3,879 Reduced 30.11%	9,005 $510,000
Q1 2021 May 06, 2021	BUY	$39.71 - $90.58 $167,854 - $382,881	4,227 Added 48.83%	12,884 $541,000
Q4 2020 Feb 09, 2021	BUY	$27.07 - $84.35 $41,390 - $128,971	1,529 Added 21.45%	8,657 $607,000
Q3 2020 Nov 10, 2020	BUY	$28.06 - $37.16 $2,469 - $3,270	88 Added 1.25%	7,128 $200,000
Q2 2020 Aug 06, 2020	SELL	$18.5 - $34.34 $1,850 - $3,434	-100 Reduced 1.4%	7,040 $208,000
Q1 2020 May 11, 2020	BUY	$14.88 - $32.78 $21,665 - $47,727	1,456 Added 25.62%	7,140 $142,000
Q4 2019 Feb 05, 2020	SELL	$19.49 - $32.63 $13,058 - $21,862	-670 Reduced 10.54%	5,684 $165,000
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $24,941 - $29,732	1,109 Added 21.14%	6,354 $144,000
Q2 2019 Aug 08, 2019	SELL	$20.48 - $27.76 $9,256 - $12,547	-452 Reduced 7.93%	5,245 $130,000
Q1 2019 Apr 26, 2019	BUY	$19.43 - $26.41 $10,433 - $14,182	537 Added 10.41%	5,697 $139,000
Q4 2018 Feb 08, 2019	BUY	$18.19 - $31.79 $23,901 - $41,772	1,314 Added 34.17%	5,160 $113,000
Q3 2018 Nov 13, 2018	BUY	$27.65 - $38.39 $106,341 - $147,647	3,846 New	3,846 $122,000

Others Institutions Holding EDIT

# of Institutions

247

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $166M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Editas Medicine, Inc. Transaction History